Acadia Pharmaceuticals ACAD Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's payments to acquire property, plant, and equipment?
- Acadia Pharmaceuticals (ACAD) reported payments to acquire property, plant, and equipment of $5.21M in Q1 2026.
- What is the long-term trend for Acadia Pharmaceuticals's payments to acquire property, plant, and equipment?
- Over 3 years (2021 to 2025), Acadia Pharmaceuticals's payments to acquire property, plant, and equipment has grown at a 61.1% compound annual growth rate (CAGR), from $1.12M to $4.69M.